Martin E. Gutierrez, MD Director, Phase I Program, Co-Chair of Thoracic Oncology, John Theurer Cancer Center and Hackensack Meridian Health shares the impact of the RELAY trial on his approach to managing first line EGFR mutant non-small cell lung cancer (NSCLC).
Implications of the RELAY Trial
